NI-0101: Clinical Trials

1 trial of NI-0101, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow NI-0101: new trials by email Literature Review of NI-0101 trials Research Report on NI-0101

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of an Anti-TLR4 mAb in Rheumatoid Arthritis
NI-0101, Placebo - Rheumatoid Arthritis
Phase 2CompletedLight Chain Bioscience - Novimmune SA902017-05-102018-08-14

Conditions studied

Arthritis, Rheumatoid (1)

Sponsors

Light Chain Bioscience - Novimmune SA (1)

Countries

Bosnia and Herzegovina (1)  ·  Bulgaria (1)  ·  Georgia (1)  ·  Hungary (1)  ·  Moldova (1)  ·  Poland (1)  ·  Serbia (1)

Top investigators

Ernest Choy, MD (1)

NIH funding

2016 (1)